Patents by Inventor Daniel Swain

Daniel Swain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12344655
    Abstract: The present invention relates to, inter alia, an engineered cell (e.g., iPSC, IPS-derived NK, or NK cell) comprising a disrupted B2M gene and an inserted polynucleotide encoding one or more of SERPINB9, a fusion of IL15 and IL15R?, and/or HLA-E. The engineered cell can further comprise a disrupted CIITA gene and an inserted polynucleotide encoding a CAR, wherein the CAR can be an anti-BCMA CAR or an anti-CD30 CAR. The engineered cell may further comprise a disrupted ADAM17 gene, a disrupted FAS gene, a disrupted CISH gene, and/or a disrupted REGNASE-1 gene. Methods for producing the engineered cells are also provided, and therapeutic uses of the engineered cells are also described. Guide RNA sequences targeting described target sequences are also described.
    Type: Grant
    Filed: December 19, 2022
    Date of Patent: July 1, 2025
    Assignee: CRISPR THERAPEUTICS AG
    Inventors: Valentin Sluch, Alireza Rezania, Jason Sagert, Danielle Swain
  • Patent number: 12172757
    Abstract: There is provided a blower system for providing air to an airframe system, comprising a rotor configured to be mechanically coupled to a spool 440 of a gas turbine engine, wherein the rotor is configured to: in a blower mode, be driven to rotate by the spool to discharge air to an airframe discharge port for supply to an airframe system; and, in an engine drive mode, receive air from an external air source via an impingement port that is configured to direct the received air onto the rotor and thereby drive the rotor to rotate to drive the spool to.
    Type: Grant
    Filed: January 17, 2023
    Date of Patent: December 24, 2024
    Assignees: Rolls-Royce PLC, Rolls-Royce Corporation
    Inventors: Christopher A. Murray, Nicholas Howarth, Daniel Swain, Ian J. Bousfield
  • Patent number: 12017790
    Abstract: An auxiliary power unit (10) for an aircraft (1) comprises a gas turbine engine comprising an engine core (12). The engine core comprises a core compressor (14) and core turbine (18) coupled by a core shaft (24). The auxiliary power unit further comprises a load spool comprising a load compressor (30), a load turbine (20) and a permanent magnet electric machine (28), each being coupled by a load shaft (26). The load shaft (26) and core shaft (24) are configured to rotate independently of one another.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: June 25, 2024
    Assignees: ROLLS-ROYCE plc, ROLLS-ROYCE CORPORATION
    Inventors: Daniel Swain, Rory D. Stieger, Mark D. Taylor
  • Publication number: 20230242260
    Abstract: There is provided a blower system for providing air to an airframe system, comprising a rotor configured to be mechanically coupled to a spool 440 of a gas turbine engine, wherein the rotor is configured to: in a blower mode, be driven to rotate by the spool to discharge air to an airframe discharge port for supply to an airframe system; and, in an engine drive mode, receive air from an external air source via an impingement port that is configured to direct the received air onto the rotor and thereby drive the rotor to rotate to drive the spool to.
    Type: Application
    Filed: January 17, 2023
    Publication date: August 3, 2023
    Applicants: ROLLS-ROYCE plc, Rolls-Royce Corporation
    Inventors: Christopher A. MURRAY, Nicholas HOWARTH, Daniel SWAIN, Ian J. BOUSFIELD
  • Publication number: 20230227532
    Abstract: The present invention relates to, inter alia, an engineered cell (e.g., iPSC, IPS-derived NK, or NK cell) comprising a disrupted B2M gene and an inserted polynucleotide encoding one or more of SERPINB9, a fusion of IL15 and IL15R?, and/or HLA-E. The engineered cell can further comprise a disrupted CIITA gene and an inserted polynucleotide encoding a CAR, wherein the CAR can be an anti-BCMA CAR or an anti-CD30 CAR. The engineered cell may further comprise a disrupted ADAM17 gene, a disrupted FAS gene, a disrupted CISH gene, and/or a disrupted REGNASE-1 gene. Methods for producing the engineered cells are also provided, and therapeutic uses of the engineered cells are also described. Guide RNA sequences targeting described target sequences are also described.
    Type: Application
    Filed: December 19, 2022
    Publication date: July 20, 2023
    Inventors: Valentin SLUCH, Alireza REZANIA, Jason SAGERT, Danielle SWAIN
  • Patent number: 11591381
    Abstract: The present invention relates to, inter alia, an engineered cell (e.g., iPSC, IPS-derived NK, or NK cell) comprising a disrupted B2M gene and an inserted polynucleotide encoding one or more of SERPINB9, a fusion of IL15 and IL15R?, and/or HLA-E. The engineered cell can further comprise a disrupted CIITA gene and an inserted polynucleotide encoding a CAR, wherein the CAR can be an anti-BCMA CAR or an anti-CD30 CAR. The engineered cell may further comprise a disrupted ADAM17 gene, a disrupted FAS gene, a disrupted CISH gene, and/or a disrupted REGNASE-1 gene. Methods for producing the engineered cells are also provided, and therapeutic uses of the engineered cells are also described. Guide RNA sequences targeting described target sequences are also described.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: February 28, 2023
    Assignee: CRISPR THERAPEUTICS AG
    Inventors: Valentin Sluch, Alireza Rezania, Jason Sagert, Danielle Swain
  • Patent number: 11566562
    Abstract: A gas turbine engine comprises, in fluid flow series, a gas-generator compressor, a combustor, a gas-generator turbine, and a free power turbine. The gas-generator compressor is an axi-centrifugal compressor comprising a plurality of axial compression stages followed by a single centrifugal compression stage, wherein the International Standard Atmosphere, sea-level static (hereinafter ISA SLS) design point pressure ratio of the axi-centrifugal compressor is from 12 to 16, and a ratio of the ISA SLS pressure rise across the axial compression stages to the ISA SLS pressure rise across the centrifugal compression stage is from 0.75 to 1.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: January 31, 2023
    Assignees: ROLLS-ROYCE PLC, ROLLS-ROYCE CORPORATION
    Inventors: Rory D. Stieger, Daniel Swain
  • Publication number: 20230014010
    Abstract: Provided herein are cells engineered to have improved protection against natural killer cell killing. The cells are engineered to comprise an insertion of a polynucleotide encoding SERPINB9. Also provided herein are methods of making the engineered cells and therapeutic uses of the engineered cells. The engineered cells can also comprise at least one genetic modification within or near at least one gene that encodes one or more MHC-I or MHC-II human leukocyte antigens or component or transcriptional regulator of the MHC-I or MHC-II complex, at least one genetic modification that increases the expression of at least one polynucleotide that encodes a tolerogenic factor, and optionally at least one genetic modification that increases or decreases the expression of at least one gene that encodes a survival factor. The engineered cells can be stem cells and the engineered stem cells can be differentiated into various lineages having protection against NK cell killing.
    Type: Application
    Filed: June 1, 2022
    Publication date: January 19, 2023
    Applicant: CRISPR THERAPEUTICS AG
    Inventors: Valentin SLUCH, Danielle SWAIN, Alireza REZANIA
  • Publication number: 20230016422
    Abstract: Provided herein are cells engineered to have improved protection against natural killer cell killing. The cells are engineered to comprise an insertion of a polynucleotide encoding SERPINB9. Also provided herein are methods of making the engineered cells and therapeutic uses of the engineered cells. The engineered cells can also comprise at least one genetic modification within or near at least one gene that encodes one or more MHC-I or MHC-II human leukocyte antigens or component or transcriptional regulator of the MHC-I or MHC-II complex, at least one genetic modification that increases the expression of at least one polynucleotide that encodes a tolerogenic factor, and optionally at least one genetic modification that increases or decreases the expression of at least one gene that encodes a survival factor. The engineered cells can be stem cells and the engineered stem cells can be differentiated into various lineages having protection against NK cell killing.
    Type: Application
    Filed: June 1, 2022
    Publication date: January 19, 2023
    Applicant: CRISPR THERAPEUTICS AG
    Inventors: Valentin SLUCH, Danielle SWAIN, Alireza REZANIA
  • Publication number: 20220235698
    Abstract: A gas turbine engine comprises, in fluid flow series, a gas-generator compressor, a combustor, a gas-generator turbine, and a free power turbine. The gas-generator compressor is an axi-centrifugal compressor comprising a plurality of axial compression stages followed by a single centrifugal compression stage, wherein the International Standard Atmosphere, sea-level static (hereinafter ISA SLS) design point pressure ratio of the axi-centrifugal compressor is from 12 to 16, and a ratio of the ISA SLS pressure rise across the axial compression stages to the ISA SLS pressure rise across the centrifugal compression stage is from 0.75 to 1.
    Type: Application
    Filed: April 19, 2022
    Publication date: July 28, 2022
    Applicants: ROLLS-ROYCE plc, ROLLS-ROYCE CORPORATION
    Inventors: Rory D. STIEGER, Daniel SWAIN
  • Publication number: 20220169700
    Abstract: The present invention relates to, inter alia, an engineered cell (e.g., iPSC, IPS-derived NK, or NK cell) comprising a disrupted B2M gene and an inserted polynucleotide encoding one or more of SERPINB9, a fusion of IL15 and IL15R?, and/or HLA-E. The engineered cell can further comprise a disrupted CIITA gene and an inserted polynucleotide encoding a CAR, wherein the CAR can be an anti-BCMA CAR or an anti-CD30 CAR. The engineered cell may further comprise a disrupted ADAM17 gene, a disrupted FAS gene, a disrupted CISH gene, and/or a disrupted REGNASE-1 gene. Methods for producing the engineered cells are also provided, and therapeutic uses of the engineered cells are also described. Guide RNA sequences targeting described target sequences are also described.
    Type: Application
    Filed: November 30, 2021
    Publication date: June 2, 2022
    Inventors: Viktoriia KYRYCHENKO, Wai Lun LEUNG, Alireza REZANIA, Valentin SLUCH, Danielle SWAIN, Patrick Claudio OVANDO ROCHE
  • Publication number: 20220169988
    Abstract: The present invention relates to, inter alia, an engineered cell (e.g., iPSC, IPS-derived NK, or NK cell) comprising a disrupted B2M gene and an inserted polynucleotide encoding one or more of SERPINB9, a fusion of IL15 and IL15R?, and/or HLA-E. The engineered cell can further comprise a disrupted CIITA gene and an inserted polynucleotide encoding a CAR, wherein the CAR can be an anti-BCMA CAR or an anti-CD30 CAR. The engineered cell may further comprise a disrupted ADAM17 gene, a disrupted FAS gene, a disrupted CISH gene, and/or a disrupted REGNASE-1 gene. Methods for producing the engineered cells are also provided, and therapeutic uses of the engineered cells are also described. Guide RNA sequences targeting described target sequences are also described.
    Type: Application
    Filed: November 30, 2021
    Publication date: June 2, 2022
    Inventors: Viktoriia KYRYCHENKO, Wai Lun LEUNG, Alireza REZANIA, Valentin SLUCH, Danielle SWAIN, Patrick Claudio OVANDO ROCHE
  • Patent number: 11339714
    Abstract: A gas turbine engine comprises, in fluid flow series, a gas-generator compressor, a combustor, a gas-generator turbine, and a free power turbine. The gas-generator compressor is an axi-centrifugal compressor comprising a plurality of axial compression stages followed by a single centrifugal compression stage, wherein the International Standard Atmosphere, sea-level static (hereinafter ISA SLS) design point pressure ratio of the axi-centrifugal compressor is from 12 to 16, and a ratio of the ISA SLS pressure rise across the axial compression stages to the ISA SLS pressure rise across the centrifugal compression stage is from 0.75 to 1.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: May 24, 2022
    Assignees: ROLLS-ROYCE PLC, ROLLS-ROYCE CORPORATION
    Inventors: Rory D Stieger, Daniel Swain
  • Publication number: 20210222630
    Abstract: A turboshaft gas turbine engine comprises, in fluid flow series, a gas-generator compressor, a combustor, a gas-generator turbine, and a free power turbine. The gas-generator turbine is a single stage turbine having a specific work of from 200 to 350 kilojoules per kilogram, said specific work being the power output of the turbine per unit mass flow therethrough.
    Type: Application
    Filed: October 1, 2020
    Publication date: July 22, 2021
    Applicants: ROLLS-ROYCE plc, ROLLS-ROYCE CORPORATION, ROLLS-ROYCE DEUTSCHLAND LTD & CO KG
    Inventors: Mark D. TAYLOR, Erik JANKE, Rory D. STIEGER, Daniel SWAIN
  • Publication number: 20210222616
    Abstract: A gas turbine engine comprises, in fluid flow series, a gas-generator compressor, a combustor, a gas-generator turbine, and a free power turbine. The gas-generator compressor is an axi-centrifugal compressor comprising a plurality of axial compression stages followed by a single centrifugal compression stage, wherein the International Standard Atmosphere, sea-level static (hereinafter ISA SLS) design point pressure ratio of the axi-centrifugal compressor is from 12 to 16, and a ratio of the ISA SLS pressure rise across the axial compression stages to the ISA SLS pressure rise across the centrifugal compression stage is from 0.75 to 1.
    Type: Application
    Filed: October 1, 2020
    Publication date: July 22, 2021
    Applicants: ROLLS-ROYCE plc, ROLLS-ROYCE CORPORATION
    Inventors: Rory D STIEGER, Daniel SWAIN
  • Publication number: 20210122488
    Abstract: An auxiliary power unit (10) for an aircraft (1) comprises a gas turbine engine comprising an engine core (12). The engine core comprises a core compressor (14) and core turbine (18) coupled by a core shaft (24). The auxiliary power unit further comprises a load spool comprising a load compressor (30), a load turbine (20) and a permanent magnet electric machine (28), each being coupled by a load shaft (26). The load shaft (26) and core shaft (24) are configured to rotate independently of one another.
    Type: Application
    Filed: October 1, 2020
    Publication date: April 29, 2021
    Applicants: ROLLS-ROYCE PLC, ROLLS-ROYCE CORPORATION
    Inventors: Daniel SWAIN, Rory D. STIEGER, Mark D. TAYLOR
  • Patent number: 7511500
    Abstract: Narrowband quadrupole resonance (QR) probes were developed from thin-film high-temperature superconducting (HTS) resonators. The QR probes are useful in analyte-detection systems, in particular for the detection of nitrogen-containing compounds. Embodiments of the invention provide greater than an order of magnitude improvement in sensitivity and the ability to reject RF interference sources located outside the pass-band of a superconducting QR probe. Methods and apparatus are described for analyte detection and resonance frequency adjustment.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: March 31, 2009
    Assignee: The Penn State Research Foundation
    Inventors: Jeffrey L. Schiano, Daniel Swain, Michael A. Pusateri
  • Publication number: 20080001602
    Abstract: Narrowband quadrupole resonance (QR) probes were developed from thin-film high-temperature superconducting (HTS) resonators. The QR probes are useful in analyte-detection systems, in particular for the detection of nitrogen-containing compounds. Embodiments of the invention provide greater than an order of magnitude improvement in sensitivity and the ability to reject RF interference sources located outside the pass-band of a superconducting QR probe. Methods and apparatus are described for analyte detection and resonance frequency adjustment.
    Type: Application
    Filed: February 27, 2007
    Publication date: January 3, 2008
    Applicant: The Penn State Research Foundation
    Inventors: Jeffrey Schiano, Daniel Swain, Michael Pusateri
  • Publication number: 20070103801
    Abstract: A vehicle mirror assembly having a housing or base member, a mirror lens and a bezel member. The mirror lens is provided in the shape of a portion of an end of an ellipsoid and has a varying radius of curvature. The center portion of the lens has a smaller radius of curvature than the outer portions along the major axis of the lens creating an improved field of view of the reflected image. The bezel is positioned over the intersection of the housing and mirror lens.
    Type: Application
    Filed: December 29, 2006
    Publication date: May 10, 2007
    Applicant: MIRROR LITE
    Inventors: William Schmidt, Daniel Swain
  • Publication number: 20070103800
    Abstract: A vehicle mirror assembly having a housing or base member, a mirror lens and a connecting gasket member. The mirror lens is provided in the shape of a portion of an end of an ellipsoid. The lens has a varying radius of curvature, The center portion of the lens has a smaller radius of curvature than the outer portions along the major axis of the lens creating an improved field of view of the reflected image.
    Type: Application
    Filed: December 28, 2006
    Publication date: May 10, 2007
    Applicant: MIRROR LITE
    Inventors: William Schmidt, Daniel Swain